Annual CMC Conference -
Kongress / Konferenz
von FORUM Institut für Management GmbH
Update on QbD, Valsartan, CEP, data integrity, ICH Q12,...
- Impurities in active substances - Lessons learned from Valsartan - Revisions of CEPs - ICH Q12 - less burden due to quality related changes? - Workshop: Quality related changes - Quality requirements of medicinal products containing a device componentThis conference addresses quality-related questions from the CTD compilation to quality changes/variations.
Do you work in regulatory affairs/CMC or quality assurance?Then you shouldnt miss out on this event. This conference will address very practical questions and provide strategic information on future CMC trends.Join the in-depth discussion on new developments, including: - Impurities - CEP - ICH Q12 - Manufacturing with QbD elements - and much more.I very much look forward to seeing you at the conference!Kind regards,Laura VogelmannConference Manager Pharma & Healthcare
This conference will be of interest to anyone working in the pharmaceutical industry and dealing with CMC issues. Those working in the following departments will particularly benefit from this event: - Marketing authorisation/regulatory affairs/CMC - Quality assurance/quality control/analytics - Production